Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial

A recombinant, replication-competent vesicular stomatitis virus-based vaccine expressing a surface glycoprotein of Zaire Ebolavirus (rVSV-ZEBOV) is a promising Ebola vaccine candidate. The researchers report the results of an interim analysis of a trial of rVSV-ZEBOV in Guinea, west Africa.

Read More
Publication Date: 
31/07/2015
Ana Maria Henao-Restrepo, Ira M Longini, Matthias Egger & et al
Lancet
1-10
Tags:
Ebola Virus Disease ( Ebola Hemorrhagic Fever), Drugs, Medical Research, Guinea, Africa, Vaccination